Fortress Biotech
FBIO
55 hedge funds and large institutions have $17.9M invested in Fortress Biotech in 2026 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 10 closing their positions.
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
19% more capital invested
Capital invested by funds: $15M → $17.9M (+$2.91M)
6% more funds holding
Funds holding: 52 → 55 (+3)
0.31% more ownership
Funds ownership: 17.27% → 17.57% (+0.31%)
28% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 18
83% less call options, than puts
Call options by funds: $260K | Put options by funds: $1.57M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$1.43M |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$527K |
| 3 |
Goldman Sachs
New York
|
+$249K |
| 4 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$184K |
| 5 |
IQI
Integrated Quantitative Investments
Bellevue,
Washington
|
+$177K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Northern Trust
Chicago,
Illinois
|
-$429K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$422K |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$392K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$266K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$212K |
FBIO Hedge Fund Activity: Q2 2026 in Review
55 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2026, worth a combined $17.9M — up 19% from $15M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new FBIO positions and 10 closed out — a net gain of 3 holders — while 13 added to existing stakes and 18 trimmed.
The largest buyer was Mackenzie Financial, opening a new position worth an estimated $1.43M. The largest seller was Northern Trust, cutting an estimated $429K.
- 55 institutional investors held Fortress Biotech (FBIO) as of Q2 2026, up from 52 in Q1 2026.
- Funds reported $17.9M of Fortress Biotech stock for Q2 2026, up 19% quarter-over-quarter.
- 13 funds opened new Fortress Biotech positions in Q2 2026 and 10 closed out, a net change of +3 holders.
- The largest Fortress Biotech buyer in Q2 2026 was Mackenzie Financial, an estimated $1.43M added.
- The largest Fortress Biotech seller in Q2 2026 was Northern Trust, an estimated $429K sold.
Based on aggregated 13F filings for Q2 2026.